Full Text View
Tabular View
No Study Results Posted
Related Studies
Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects
This study has been completed.
Study NCT00514904   Information provided by GlaxoSmithKline

First Received on August 9, 2007.   Last Updated on January 12, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Meningococcal Disease
Additional conditions recognized in this trial
Meningococcal Infections
More general conditions related to this trial
Bacterial Infections
Gram-Negative Bacterial Infections
Neisseriaceae Infections
Interventions listed in this trial
Meningococcal vaccine GSK134612
Mencevax™
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services